Sun Pharma buying $11.75bn US pharma group Organon
In a move that significantly reshapes the global pharmaceutical landscape, American pharmaceutical company Organon is being acquired by listed Indian drugmaker Sun Pharmaceutical Industries. A definitive agreement has been signed in an all cash transaction valuing the target at an enterprise valuation of $11.75bn. The integration of Organon, which was spun out of Merck in 2021, immediately establishes Sun Pharma…